The present disclosure relates generally to automated diagnostic analyzers and, more particularly, to automated diagnostic analyzers having vertically arranged carousels and related methods.
Automated diagnostic analyzers employ multiple carousels and multiple pipetting mechanisms to automatically aspirate fluid from and dispense fluid to different areas in the analyzer to perform diagnostic analysis procedures. The carousels may include a carousel for reaction vessels, a carousel for samples and/or a carousel for reagents. By arranging multiple containers on the respective carousels, these known analyzers are capable of conducting multiple tests on multiple test samples as the carousels rotate. Some known carousels are arranged in a coplanar orientation, and a number of different modules or stations are disposed around the carousels to perform specific functions such as, for example, mixing the contents of a reaction vessel, washing a reaction vessel and/or a pipette, incubating a test sample, and analyzing the contents of a reaction vessel. Due to the multiple coplanar carousels and the number of modules and stations, these known automated clinical analyzers typically require a relatively large space.
Certain examples are shown in the above-identified figures and disclosed in detail below. In describing these examples, like or identical reference numbers are used to identify the same or similar elements. The figures are not necessarily to scale and certain features and certain views of the figures may be shown exaggerated in scale or in schematic for clarity and/or conciseness. Additionally, several examples have been described throughout this specification. Any features from any example may be included with, a replacement for, or otherwise combined with other features from other examples.
Diagnostics laboratories employ diagnostic instruments such as those for testing and analyzing specimens or samples including, for example, clinical chemistry analyzers, immunoassay analyzers and hematology analyzers. Specimens and biological samples are analyzed to, for example, check for the presence or absence of an item of interest including, for example, a specific region of DNA, mitochondrial DNA, a specific region of RNA, messenger RNA, transfer RNA, mitochondrial RNA, a fragment, a complement, a peptide, a polypeptide, an enzyme, a prion, a protein, an antibody, an antigen, an allergen, a part of a biological entity such as a cell or a viron, a surface protein, and/or functional equivalent(s) of the above. Specimens such as a patient's body fluids (e.g., serum, whole blood, urine, swabs, plasma, cerebra-spinal fluid, lymph fluids, tissue solids) can be analyzed using a number of different tests to provide information about the patient's health.
Generally, analysis of a test sample involves the reaction of test samples with one or more reagents with respect to one or more analytes. The reaction mixtures are analyzed by an apparatus for one or more characteristics such as, for example, the presence and/or concentration of a certain analyte in the test sample. Use of automated diagnostic analyzers improves the efficiency of the laboratory procedures because the technician (e.g., an operator) has fewer tasks to perform and, thus, the potential for operator or technician error is reduced. In addition, automated diagnostic analyzers also provide results much more rapidly and with increased accuracy and repeatability.
Automated diagnostic analyzers use multiple pipettes to move liquids between storage containers (e.g., receptacles such as open topped tubes) and containers in which the specimens are to be processed (e.g., reaction vessels). For example, a specimen may be contained in a tube loaded in a rack on an analyzer, and a head carrying a pipette moves the pipette into the tube where a vacuum is applied to extract a selected amount of the specimen from the tube into the pipette. The head retracts the pipette from the tube and moves to another tube or reaction vessel located at a processing station and deposits the extracted specimen from the pipette into the reaction vessel. A reagent is similarly acquired from a reagent supply.
The example automated diagnostic analyzers disclosed herein position a first carousel (e.g., a reaction carousel, a reagent carousel, a sample carousel) above at least a portion of a second carousel (e.g., a reaction carousel, a reagent carousel, a sample carousel) to reduce lab space, increase throughput and decrease sample testing time (e.g., turnaround time). The example automated diagnostic analyzers also locate one or more pipetting mechanism(s) within the outer diameters of one of more of the carousels to further reduce the dimensions (e.g., the footprint) of the analyzer and decrease the distanced traveled by the respective pipetting mechanisms. The example automated diagnostic analyzers can simultaneously perform two or more tests on a plurality of test samples in a continuous and random access fashion. Test steps such as aspirating/dispensing, incubations, washes and specimen dilution are performed automatically by the instrument as scheduled. By utilizing vertically arranged or stacked carousels, the foot print or floor space required for the overall system is reduced. Additionally, the distanced traveled by the pipetting mechanism is also reduced, which decreases turnaround time and, thus, increases the throughput of the example analyzer. For example, in some examples, the example analyzers disclosed herein perform up to about 956 tests per hour. Further, because the carousels are stacked vertically, carousels with larger diameters and, thus, higher capacity than known analyzers may be incorporated into the example analyzers. The higher capacity analyzers occupy less space than lower capacity analyzers that have a coplanar carousel configuration. The example analyzers with smaller footprints, higher throughputs and shorter turnaround times are advantageous to the operations of hospitals, laboratories, and other research facilities that utilize diagnostic analyzers.
An example apparatus disclosed herein includes a first carousel rotatably coupled to a base and having a first diameter and a first axis of rotation. The example apparatus includes a second carousel rotatably coupled to the base and vertically spaced over the first carousel such that at least a portion of the second carousel is disposed over the first carousel. In the example apparatus, the second carousel has a second diameter, a second axis of rotation and a plurality of vessels. The example apparatus also includes a first pipetting mechanism offset from the second axis of rotation. The example first pipetting mechanism is to access the first carousel and the second carousel. In some examples, the example first pipetting mechanism is disposed within the first diameter and the second diameter and offset from the second axis of rotation.
In some examples, the first axis of rotation and the second axis are parallel to and offset from each other. In some examples, the second diameter is less than the first diameter.
In some examples, the apparatus includes a second pipetting mechanism to access the first carousel and the second carousel. In some examples, the second pipetting mechanism is disposed within the first diameter and outside of the second diameter. In some examples, the first carousel comprises an outer annular array of containers and an inner annular array of containers concentric with the outer annular array and the first pipetting mechanism is to access at least one of the inner annular array of containers or the vessels, and the second pipetting mechanism to access at least one of the outer annular array of containers or the vessels. In some examples, the first pipetting mechanism comprises a first pipette arm movable (e.g., rotatable) along a first path of travel over a first inner container of the inner annular array of containers and a first vessel of the plurality of vessels. In some such examples, the second pipette mechanism comprises a second pipette arm movable (e.g., rotatable) along a second path of travel over a second outer container of the outer annular array of containers and a second vessel of the plurality of vessels. In some examples, the second pipetting mechanism is offset from the first axis of rotation.
In some examples, the apparatus comprises a third pipetting mechanism. In some examples, the third pipetting mechanism is to access only the first carousel. In some examples, the third pipetting mechanism is disposed outside of the first diameter and outside of the second diameter. In some such examples, the third pipetting mechanism comprises a third pipette arm movable (e.g., rotatable) along a third path of travel over a container outside of the first diameter and the second diameter and over a third vessel of the plurality of vessels.
In some examples, the apparatus includes a plate coupled to the base disposed between the first carousel and the second carousel, the second carousel being rotatably coupled to the plate. In some such examples, the second pipetting mechanism is coupled to the plate.
In some examples, first carousel further comprises a middle annular array of containers spaced radially between the outer annular array of containers and the inner annular array of containers.
In some examples, the second carousel is to rotate in a plurality of intervals, each interval comprising an advancement and a stop. In some such examples, the second carousel is operable to rotate approximately 90° during the advancement of one of the intervals. In some examples, the second carousel is stationary during the stop of one of the intervals, a duration of the stop being greater than a duration of the advancement of the interval.
In some examples, the first carousel is to rotate in a plurality of intervals, each interval comprising an advancement and a stop. In some such examples, the first carousel is operable to rotate approximately 180° during the advancement of one of the intervals, a duration of the advancement being about one second of the interval.
In some examples, the apparatus includes a servo motor to rotate one or more of the first carousel or the second carousel.
In some examples, the outer annular array of containers on the first carousel contain a first type of reagent and the inner annular array of containers on the first carousel contain a second type of reagent different than the first type of reagent.
In some examples, the containers of the first carousel are reagent containers, and the vessels of the second carousel are reaction vessels. In some examples, the first pipetting mechanism comprises a probe arm having a vertically descending portion
In another example disclosed herein, an apparatus includes a reagent carousel rotatably coupled to a base about a first axis of rotation. The example apparatus also includes a reaction carousel rotatably coupled to the base about a second axis of rotation, the reaction carousel disposed above the reagent carousel. In addition, the example apparatus includes a first pipette in fluid communication with the reagent carousel and the reaction carousel.
Also, in some examples disclosed herein the example apparatus includes a reagent container disposed on the reagent carousel and a reagent in the reagent container. In addition, the example apparatus includes a reaction vessel disposed on the reaction carousel. In such examples, the first pipette is to aspirate a portion of the reagent from the reagent container, move upward vertically, then dispense the portion of the reagent into the reaction vessel.
In some examples, the example apparatus also includes a second pipette to aspirate a sample from a sample container apart from the reagent carousel and the reaction carousel and dispense the sample into the reaction vessel.
An example method disclosed herein includes rotating a first carousel relative to a base, the first carousel having a first diameter, a first axis of rotation, an outer annular array of containers and an inner annular array of containers concentric with the outer annular array. The example method includes rotating a second carousel relative to the base, the second carousel having a second diameter, a second axis of rotation and a plurality of vessels and being vertically spaced over the first carousel such that at least a portion of the second carousel is disposed over the first carousel. The example method also includes aspirating a first fluid from a first carousel via a first pipetting mechanism offset from the second axis of rotation. In some examples, the first pipetting mechanism is disposed within the first diameter and within the second diameter.
In some examples, the method includes aspirating a second fluid from the first carousel via a second pipetting mechanism. In some examples, the second pipetting mechanism is disposed within the first diameter an outside of the second diameter. In some examples, the method also includes accessing at least one of the inner annular array of containers or the vessels with the first pipetting mechanism and accessing at least one of the outer annular array of containers or the vessels with the second pipetting mechanism. In some examples, the method includes rotating a first pipette arm of the first pipetting mechanism along a first path of travel over a first inner container of the inner annular array of containers and a first vessel. In some such examples, the method also includes rotating a second pipette arm of the second pipetting mechanism along a second path of travel over a first outer container of the outer annular array of containers and a second vessel. In some examples, the second pipetting mechanism is offset from the first axis of rotation.
In some examples, the method includes aspirating a third fluid via a third pipetting mechanism. In some examples, the third pipetting mechanism is disposed outside of the first diameter and outside of the second diameter. In some such examples, the method includes rotating a third pipette arm of the third pipetting mechanism along a third path of travel over a container outside of the first diameter and the second diameter and over a third vessel of the plurality of vessels.
In some examples, the method includes rotating the second carousel in a plurality of intervals, each interval comprising an advancement and a stop. In some such examples, the method includes rotating the second carousel approximately 90° during the advancement of one of the intervals. In some examples, the method includes idling the second carousel during the stop of one of the intervals, a duration of the stop being greater than a duration of an advancement of the interval.
In some examples, the method includes accessing a first vessel on the second carousel with the first pipetting mechanism, rotating the second carousel in a plurality of intervals, and rotating the second carousel for two or more intervals for the first pipetting mechanism to access a second vessel, the second vessel being physically adjacent to the first vessel.
In some examples, the method includes rotating the first carousel in a plurality of intervals, each interval comprising an advancement and a stop. In some such examples, the method includes rotating the first carousel approximately 180° during the advancement of one of the intervals, a duration of the advancement being about one second of the interval.
In some examples, the method includes activating a servo motor to rotate one or more of the first carousel or the second carousel.
Turning now to the figures, a portion of an example automated diagnostic analyzer 100 is shown in partially exploded views
In the example shown in
In view of the example analyzer 100 shown in
In some examples, the first carousel 102 has more than two annular arrays of containers (e.g., three, four or more) spaced radially apart from one another on the first carousel 102. In some examples, the containers are disposed in carriers that are loaded into the slots 103a-n of the first carousel 102. In some examples, each of the carriers may container one, two, three, four or more containers and, when disposed on the first carousel 102, define the annular arrays of containers. In some examples, the first carousel 102 includes 72 slots 103a-n to receive up to 72 carriers. In other examples, the first carousel 102 may include 45 slots 103a-n to receive up to 45 carriers. In some examples, each carrier (e.g., a kit) includes a volume of testing liquid (e.g., reagent) to supply or support about 50 to about 1700 tests. Other examples include different numbers of slots, different numbers of carriers and different volumes of testing liquids.
In the example shown, the second carousel 104 has a plurality of reaction vessels 112a-n disposed around an outer circumference of the second carousel 104. In the example shown, the reaction vessels 112a-n are reusable cuvettes (e.g., washable glass cuvettes). After a test has been completed in one of the reaction vessels 112a-n, the vessel 112a-n is cleaned (e.g., sterilized), and the vessel 112a-n may be used for another test. However, in other examples, the reaction vessels 112a-n are disposable cuvettes (e.g., plastic cuvettes) that are discarded after one or more tests. In some examples, the second carousel 104 includes an unloading mechanism 113 (e.g., a passive unloader or an active unloader) for removing the reaction vessels 112a-n (e.g., disposable cuvettes) from the second carousel 104. In some examples, the unloading mechanism 113 is positioned such that when one of the reaction vessels 112a-n is unloaded from the second carousel 104, the unloaded reaction vessel 112a-n falls through the bore 105 of the first carousel 102 and into a waste container or other receptacle disposed within the base station 106. In some examples, the second carousel 104 includes more than one unloading mechanism, and the unloading mechanisms may be disposed in other locations around the second carousel 104.
As illustrated more clearly in
In the example shown in
The example automated diagnostic analyzers disclosed herein also include one or more pipetting mechanisms (e.g., probe arms, automated pipettes, etc.). In the illustrated examples shown in
As illustrated in
After aspirating fluid from the appropriate container on the first carousel 102, the first pipetting mechanism 130 moves vertically upward and moves the first probe arm 132 along the first path of travel 134 (e.g., rotates or pivots clockwise) until the first pipette 136 is at point A, at which point the first pipette 136 is aligned vertically over one of the plurality of vessels 112a-n on the second carousel 104. In some examples, the first pipetting mechanism 130 dispenses the liquid (e.g., the liquid including any microparticles aspirated from a container on the first carousel 102) into the vessel 112a-n on the second carousel 104 at this position (e.g., the height at which the first pipette 136 travels along the first path of travel 134). In other examples, the first pipetting mechanism 130 moves vertically downward toward the second carousel 104 and dispenses the liquid into the vessel 112a-n on the second carousel 104. In the illustrated example, the first pipetting mechanism 130 has only one access point, the first access port 138, for accessing containers on the first carousel 102 disposed below. However, in other examples, the platform 126 includes multiple access ports along the first path of travel 134 such that the first pipette 136 can access additional areas on the first carousel 102. In some examples, multiple annular arrays of containers (e.g., an inner array and an outer array or an inner array, a middle array and an outer array) are disposed on the first carousel 102 at different radial distances (e.g., along the slots 103 shown in
In the example shown, the analyzer 100 includes a second pipetting mechanism 140 that is coupled (e.g., mounted) to the platform 126. The second pipetting mechanism 140 is coupled to the platform 126 above the first carousel 102 and next to (e.g., adjacent) the second carousel 104 (i.e., within the first diameter 118 of the first carousel 102 and outside of the second diameter 120 of the second carousel 104). In the example shown, the second pipetting mechanism 140 is offset from the first axis 114 of the first carousel 102. However, in other examples, the second pipetting mechanism 140 is aligned with the first axis 114 of rotation. The second pipetting mechanism 140 has multiple degrees of freedom. In the example shown, the second pipetting mechanism 140 has a second probe arm 142 that moves along a second path of travel 144 (e.g., rotates or pivots along a horizontal arc) to aspirate/dispense fluid through a second pipette 146 disposed at a distal end of the second probe arm 142. The second path of travel 144 may be circular, semicircular, linear or a combination thereof. The second pipetting mechanism 140 is also movable in the Z direction (e.g., the vertical direction).
In the example shown, the second pipetting mechanism 140 accesses containers on the first carousel 102 through a second access port 148 formed in the platform 126. In operation, the second pipetting mechanism 140 moves (e.g., rotates or pivots) the second probe arm 142 along the second path of travel 144 until the second pipette 146 is aligned above the second access port 148. The second pipetting mechanism 140 then moves vertically downward for the second pipette 146 to access a container on the first carousel 102. In the example shown, the second pipetting mechanism 140 and the second access port 148 are positioned to allow the second pipetting mechanism to aspirate from a container disposed on the first carousel 102 below the second access port 148. As mentioned above, the first carousel 102 includes the outer annular array of containers 108a-n and the inner annular array of containers 110a-n, which may be, for example, reagents used first in a diagnostic test and reagents used second in the diagnostic test. In the illustrated example, the second pipetting mechanism 140 is positioned (e.g., aligned) to aspirate liquid including any microparticles from the outer annular array of containers 108a-n on the first carousel 102. As shown, the outer annular array of containers 108a-n rotate along the first annular path 109, which intersects with the second access port 148 and, thus, the second path of travel 144. In the example shown, a silhouette of a carrier, having two containers (e.g., an outer annular container and an inner annular container), is depicted near the second access port 148 to illustrate the interaction of the containers, the second access port 148 and/or the second path of travel 144.
After aspirating liquid and any associated microparticles from the appropriate container on the first carousel 102, the second pipetting mechanism 140 moves vertically upward and moves (e.g., rotates or pivots) the second probe arm 142 counter-clockwise along the second path of travel 144 until the second pipette 146 is at point B, at which point the second pipette 146 is aligned vertically over one of the plurality of vessels 112a-n on the second carousel 104. In some examples, the second pipetting mechanism 140 dispenses the liquid (e.g., the liquid including any microparticles aspirated from a container on the first carousel 102) into the vessel 112a-n on the second carousel 104 at this position (e.g., the height at which the second pipette 146 travels along the second path of travel 144). In other examples, the second pipetting mechanism 140 moves vertically downward toward the second carousel 104 and dispenses the liquid into the vessel 112a-n on the second carousel 104. In the illustrated example, the second pipetting mechanism 140 has one access point, the second access port 148, for accessing containers on the second carousel 104 disposed below. However, in other examples, the platform 126 includes multiple access ports along the second path of travel 144 such that the second pipette 146 can access additional areas on the first carousel 102. In some examples, multiple annular arrays of containers (e.g., an inner array and an outer array or an inner array, a middle array and an outer array) are disposed on the first carousel 102 at different radial distances and, thus, multiple access points along the second path of travel 144 will allow the second pipetting mechanism 140 to access the containers as needed.
In the illustrated examples, the analyzer 100 includes a third pipetting mechanism 150. In the example shown, the third pipetting mechanism 150 is coupled to the platform 126. In other examples, the third pipetting mechanism 150 may be coupled to the top 124 of the base station 106. In the example shown, the third pipetting mechanism 150 is disposed outside of the first diameter 118 of the first carousel 102 and outside of the second diameter 120 of the second carousel 104. However, in other examples, the third pipetting mechanism 150 is disposed within the first diameter 118 of the first carousel 102. In the example shown, the third pipetting mechanism 150 is mounted at a level above the first carousel 102. Specifically, the third pipetting mechanism 150 is mounted to the platform 126 above the first carousel 102.
The third pipetting mechanism 150 has multiple degrees of freedom. In the example shown, the third pipetting mechanism 150 has a third probe arm 152 that rotates along a third path of travel 154 (e.g., a horizontal arc) to aspirate/dispense liquid (e.g., a sample) through a third pipette 156 at a distal end of the third probe arm 152. The third path of travel 154 may be circular, semicircular, linear or a combination thereof. The third pipetting mechanism 150 is also movable in the Z direction (e.g., the vertical direction).
In the example shown, the third pipetting mechanism 150 may be used, for example, to dispense a sample (e.g., a test sample or a specimen) into one or more of the vessels 112a-n on the second carousel 104. In some examples, test samples are aspirated from sample containers (which may be in carriers) along the third path of travel 154 of the third pipetting mechanism 150. In some examples, test samples are transported to the rear of the analyzer 100 via a transporter or a positioner, and the third probe arm 152 moves (e.g., rotates or pivots) along the third path of travel 154 to align the third pipetting mechanism 150 above the sample tubes. After aspirating a sample from a sample tube, the third pipetting mechanism 150 moves (e.g., rotates or pivots) the third probe arm 152 along the third path of travel 154 until the third pipette 156 is at point C, where the third pipette 156 is vertically aligned above one of the reaction vessels 112a-n on the second carousel 104. The third pipetting mechanism 150 moves vertically downward toward the second carousel 104 and dispenses the sample into one of the vessels 112a-n on the second carousel 104.
In the example shown, three pipetting mechanisms 130, 140, 150 are employed to perform automated testing. However, in other example analyzers, more or fewer automated pipetting mechanisms may be utilized (such as, for example, one, two, four, five, etc.). For example, there may be a fourth pipetting mechanism, which also may be used to dispense samples into one of the vessels 112a-n on the second carousel 104. Also, in some examples, one or more of the pipetting mechanisms may include a double probe to enable the pipetting mechanism to aspirate from and/or dispense to two containers and/or vessels simultaneously. For example, with two probes on the third pipetting mechanism 150, the third pipetting mechanism 150 can dispense a first sample in a first vessel and a second sample in a second vessel. In addition, in some examples, the pipetting mechanisms may be located in different locations, to perform the steps for analysis. Further, in some example analyzers, the pipetting mechanisms 130, 140, 150 may aspirate from multiple sources and dispense into multiple locations (e.g., containers and vessels) along their respective paths of travel.
In the example analyzer 100 shown in
In some examples, the length of the probe arms 132, 142, 152 and/or the length of the paths of travel 134, 144, 154 are shorter than the probe arms of some known analyzers. The decreased probe arm length of the illustrated examples reduces the effects of vibrations (e.g., from the motors, mixers, etc.) on the pipetting mechanisms 130, 140, 150 because the respective pipettes 136, 146, 156 are closer to the base of the respective pipetting mechanisms 130, 140, 150 and, thus, are closer to the center of mass and are sturdier. The sturdier probes arms 132, 142, 152 enable the example pipetting mechanisms 130, 140, 150 to operate with greater accuracy. The example pipetting mechanisms 130, 140, 150 may also operate with greater speed because there is no need to wait for vibrations to dampen or otherwise subside before operation of the pipetting mechanisms 130, 140, 150. In the example shown, the first, second and third pipetting mechanisms 130, 140, 150 include respective base assemblies 135, 145, 155. In some examples, the base assemblies 135, 145, 155 include drive components and other actuating components to move the first, second and third probe arms 132, 142, 152 in the Z direction.
Although the first and second carousels 102, 104 are disclosed herein as being a reagent carousel and a reaction carousel, respectively, the teachings of this disclosure may be applied to examples in which either the first carousel 102 and/or the second carousel 104 includes reagents, reaction vessels and/or samples. Thus, the first carousel 102 may be a reaction carousel including a plurality of reaction vessels, and the second carousel 104 may be a reagent carousel including a plurality of reagent containers having reagent(s) for reacting with the samples in the reaction vessels.
In the example shown, the analyzer 100 also includes additional modules or components for performing different steps in the test process such as, for example, a mixer for mixing, a light source for lighting the reaction vessels, a reader for analyzing the test samples, a wash zone for cleaning the vessels, etc. As shown in
In the example shown, the first and second carousels 102, 104 rotate in intervals or locksteps during a diagnostic test. Each interval has an advancement step wherein the carousel moves and stop step where the carousel is idle. Depending on the type of diagnostic test performed, the carousels 102, 104 may have different lockstep times and rotational degrees that are traversed during the advancement step. In the example shown, the second carousel 104 has total a lockstep time (the combination of an advancement step and a stop step) of about four seconds (i.e., the second carousel 104 rotates incrementally to a different position about every four seconds). During the advancement step of the lockstep, the second carousel 104 rotates about 90° (e.g., about a quarter turn). In other examples, the second carousel 104 may rotate more or less depending on the scheduling protocols designed for the specific analyzer and/or for a particular diagnostic testing protocol. In some examples, the second carousel 104 rotates about 1° to about 15° during the advancement step of the lockstep. In other examples, the second carousel rotates about 15° to about 90° during the advancement step of the lockstep.
In the example shown, the advancement step may take place during about one second of the four second lockstep, and the second carousel 104 may remain idle (e.g., stationary) for about three second during the stop step of the lockstep. During these three seconds, the first, second and third pipetting mechanisms 130, 140, 150 are aspirating and/or dispensing liquids (e.g., simultaneously or in sequence), including any microparticles contained therein, and other functional modules are operating around the carousels 102, 104. Some of the functional modules such as, for example, the reader 158, also operate during the advancement step of a lockstep. Additionally or alternatively, the reader 158 operates during the stop step of a lockstep.
In some examples, the first carousel 102 has a lockstep time of about two seconds. For each lockstep, the first carousel 102 rotates during one second (e.g., an advancement step) and is idle (e.g., stationary) for one second (e.g., a stop step). The lockstep time for the first carousel 102 is half of the lockstep time for the second carousel 104 so that the first carousel 102 may be repositioned during one lockstep of the second carousel 104, and a second reagent can be aspirated from the first carousel 102 and dispensed into the second carousel 104 during one lockstep of second carousel 104. For example, a first reagent container on the outer annular array of containers 108a-n and a second reagent container on the inner annular array of container 110a-n may be on the same radial slot 103a-n on the first carousel 102. In this example, if both reagents are to be used during a single lockstep of the second carousel 104, during the first lockstep for the first carousel 102, the second pipetting mechanism 140 may aspirate a reagent from the outer annular array of containers 108a-n. After the second pipette 146 has left the container, the first carousel 102 rotates to its second lockstep position so that the first pipetting mechanism 130 can aspirate its desired reagent from the inner annular array of container 110a-n during the same lockstep of the second carousel 104. In some examples, depending on the location of the pipetting mechanisms, the first carousel 102 is rotated approximately 180° to the next position so the next pipetting mechanism can aspirate and dispense in accordance with the testing protocol. Thus, both the first and second pipetting mechanisms 130, 140 can aspirate from containers in any of the slots 103a-n of the first carousel 102 in one lockstep of the second carousel 104. In addition, in some examples, the first and second pipetting mechanisms 130, 140 may interact with the first carousel 102 during the stop step portion of the lockstep of the first carousel 102 while the second carousel 104 rotates in the advancement step of the lockstep of the second carousel 104.
In the example shown, the first carousel 502 has an outer annular section 508 for containers and an inner annular section 510 for containers. In some examples, containers on the outer annular section 508 may be, for example, reagent containers that hold a first reagent to be used in a first step in a test process, and containers on the inner annular section 510 may be, for example, reagent containers that hold a second reagent to be used either in a second step in the test process and/or in a second test process different than the first.
As shown, the first carousel 502 has a first bore 512 and a first diameter 514, and the second carousel 504 has a second bore 516 and a second diameter 518. In this example, a center of the second carousel 504 is offset from a center of the first carousel 502 and within the first diameter 516 (i.e., the second carousel 504 is disposed vertically above the first carousel 502 and positioned within the outer bounds of the first carousel 502).
The analyzer 500 includes a first pipetting mechanism 520 disposed within the first diameter 514 of the first carousel 502 and within the second diameter 518 of the second carousel 504. In the example shown, the first pipetting mechanism 520 is also disposed within the first bore 512 of the first carousel 502 and the second bore 516 of the second carousel 504. In some examples, the first pipetting mechanism 520 is mounted to the base 506. In other examples, the first pipetting mechanism 520 is mounted to a platform disposed between the first carousel 502 and the second carousel 504. In the example shown, the first pipetting mechanism 520 moves in the Z direction (e.g., vertically) and rotates or otherwise moves to aspirate/dispense liquid including liquids that have microparticles within a first probe arm radius or range of motion 522. The first probe arm radius 522 is capable of extending over a portion of the inner annular section 510 of the first carousel 502 and over a portion of the second carousel 504 such that the first pipetting mechanism 520 is able to aspirate/dispense from/to containers or vessels disposed on the inner annular section 510 of the first carousel 502 and/or containers or vessels on disposed on the second carousel 504. Thus, the first pipetting mechanism 520 may be used, for example, to aspirate a reagent from a container on the first carousel 502 and dispense the reagent into a reaction vessel on the second carousel 504.
The analyzer 500 includes a second pipetting mechanism 524 disposed outside the first diameter 514 of the first carousel 502 and outside of the second diameter 518 of the second carousel 504. In some examples, the second pipetting mechanism 524 is mounted to the base 506. In other examples, the second pipetting mechanism is mounted to a platform disposed between the first carousel 502 and the second carousel 504. The second pipetting mechanism 524 moves in the Z direction (e.g., vertically) and rotates or otherwise moves to aspirate/dispense fluid within a second probe arm radius or range of motion 526. As shown, the second probe arm radius 526 extends over a portion of the outer annular section 508 of the first carousel 502 and a portion of the second carousel 504 such that the second pipetting mechanism 524 is able to aspirate/dispense from/to containers or vessels disposed on the outer annular section 508 of the first carousel 502 and/or containers or vessels on disposed on the second carousel 504. Thus, the second pipetting mechanism 524 may be used, for example, to aspirate a reagent from a container on the first carousel 502 and dispense the reagent into a reaction vessel on the second carousel 504.
The example analyzer 500 includes a third pipetting mechanism 528 disposed outside the first diameter 514 of the first carousel 502 and outside of the second diameter 518 of the second carousel 504. In some examples, the third pipetting mechanism 528 is mounted to the base 506. In other examples, the third pipetting mechanism 528 is mounted to a platform disposed between the first carousel 502 and the second carousel 504. The third pipetting mechanism 528 moves in the Z direction (e.g., vertically) and rotates or otherwise moved to aspirate/dispense fluid within a third probe arm radius 530. As shown, the third probe arm radius or range of motion 530 extends over a portion of the outer annular section 508 of the first carousel 502, a portion of the second carousel 504, and a region outside of the base 506 of the analyzer 500. The third pipetting mechanism 528 may be used, for example, to aspirate sample from a test sample tube disposed outside of the base 506 (e.g., from another portion of the analyzer 500) and to dispense the sample into a container or vessel on the second carousel 504.
In the example shown, the inner annular section 510 and the outer annular section 508 are formed in the same carousel 502 and, thus, rotate together. However, in other examples, the inner annular section 510 and the outer annular section 508 may be separate carousels that are independently rotatable in either direction.
As shown, the first, second and third pipetting mechanisms 520, 524, 528 are disposed within the first and second diameters 514, 518 and/or in the corners of the base 506. In addition, the first carousel 502 and second carousel 504 are stacked. Thus, the footprint of the example analyzer 500 is less than an analyzer with coplanar carousels.
The example processing system 600 also includes a carousel controller 608, which controls one or more carousels of the analyzer. In the example shown, the carousel controller 608 is communicatively coupled to a first carousel 610 and a second carousel 612. The first carousel 610 and the second carousel 612 may correspond, for example, to the first and second carousels 102, 104 disclosed above in connection with the example analyzer 100. The carousel controller 608 controls the rotation of the first and second carousels 610, 612, such as, for example, using a motor (e.g., the motors 125, 127 disclosed in connection with the analyzer 100). Also, the example processor 606 operates the carousel controller 608 and, thus, the carousels 610, 612 in accordance with a schedule or testing protocol.
The example processing system 600 also includes a database 614 that may store information related to the operation of the example system 600. The information may include, for example, the testing protocol, reagent identification information, reagent volume information, sample identification information, position information related to a position (e.g., reaction vessel, lockstep and/or rotation) of a sample, status information related to the contents and/or position of a reaction vessel, pipette position information, carousel position information, lockstep duration information, etc.
The example processing system 600 also includes a user interface such as, for example, a graphical user interface (GUI) 616. An operator or technician interacts with the processing system 600 and, thus, the analyzer 100, 500 via the interface 616 to provide, for example, commands related to the testing protocols, information related to the samples to be tested, information related to the reagents or other fluids to be used in the testing, etc. The interface 616 may also be used by the operator to obtain information related to the status and/or results of any testing completed and/or in progress.
In the example shown, the processing system components 602, 606, 608, 614 are communicatively coupled to other components of the example system 600 via communication links 618. The communication links 618 may be any type of wired connection (e.g., a databus, a USB connection, etc.) and/or any type of wireless communication (e.g., radio frequency, infrared, etc.) using any past, present or future communication protocol (e.g., BLUETOOTH®, USB 2.0, USB 3.0, etc.). Also, the components of the example system 600 may be integrated in one device or distributed over two or more devices.
While an example manner of implementing the analyzers 100, 500 of
A flowchart representative of an example method 700 for implementing the analyzers 100, 500 and/or the processing system 600 of
As mentioned above, the example process 700 of
In the example process 700, the number of complete rotations of the reaction carousel is represented by the variable X, which is set to 0 at the beginning of the example process 700, and a predetermined timing of a function or test operation to be performed is represented by N1, N2, N3 and N4. In particular, in this example, N1, N2, N3 and N4 are integers that represent numbers of elapsed locksteps to be used to trigger the performance of a respective function or test operation. In other words, when N1 locksteps have elapsed or completed, a first function or test operation may be performed, when N2 lockstep have elapsed or completed, a second function or test operation may be performed and so on. As mentioned above, the reaction carousel has a lockstep rotation that is slightly more than a quarter turn. In some examples, the rotation is such that after four locksteps, or one full rotation, a given reaction vessel will be indexed one position past where the reaction vessel was in the previous rotation.
The example process includes lockstep4X+1 (block 702). At the beginning, when a full rotation has not yet occurred, X is zero, and this is the first lockstep (i.e., lockstep(4*0)+1). In this first lockstep, a function is performed on the reaction vessel if 4X+1=N1 (block 704). As noted above, N1 represents the timing or lockstep at which a specific function or test operation is performed in connection with the reaction vessel. For example, in the example analyzer 100 disclosed above, the third pipetting mechanism 150 is disposed near the reaction carousel 104 and is to dispense a sample into a reaction vessel at point C. In some examples, the first lockstep of a given test in a given reaction vessel occurs when the reaction vessel is at point C. Therefore, the function of dispensing sample, N1, may be set to 1, such that if this is the first lockstep (block 704) for the reaction vessel, the function is performed (block 706) (i.e., sample is dispensed into the reaction vessel) because 4X+1=N1 (e.g., (4*0)+1=1). In subsequent rotations, wherein N1 continues to be set to 1, and X is not zero, the reaction vessel is idle (block 708) and, for example, no functions are performed on the reaction vessel by the operator or robotic mechanisms of the example analyzer 100, 500 at this lockstep because 4X+1≠N1 (e.g., (4*1)+1≠1). Thus, in this example, if the function is to occur only at the first lockstep (e.g., dispensing a sample), then the example system will sit idle during each subsequent occurrence of a first lockstep during subsequent rotations (e.g., when X>1) until, for example, the reaction vessel is washed and ready for a subsequent test and X is reset to zero for the subsequent implementation of the example process 700.
The example process 700 includes advancing to the next lockstep (block 710) and reading (e.g., analyzing) the contents of any reaction vessel passing the reader. As mentioned above, the reaction carousel rotates about a quarter rotation every lockstep. In some examples, the reaction carousel is rotated for about one second of the four second lockstep time. During the advancement in this lockstep, about a quarter of the reaction vessels on the reaction carousel are passed in front of an analyzer (e.g., the analyzer 158) where the contents of the reaction vessels are analyzed. During the first few locksteps, all or most of the reaction vessels may be empty. However, in some examples, the reader continues to read, even if the data acquired is not used. By reading during every lockstep, the reader acquires a full range of readings during each reaction as the reactions are taking place. In other examples, the reader may delay reading for a predetermined amount of time and/or after a predetermined number reaction vessels are filled with sample and/or reagent.
The example process includes lockstep4X+2 (block 712). Assuming one full rotation has not yet occurred, X is zero and this is the second lockstep (i.e., lockstep(4*0)+2). During this second lockstep, a second function or test operation may be performed in connection with the reaction vessel if 4X+2=N2 (block 714). Similar to N1, N2 represents the specific timing of a specific function or test operation to be performed in connection with the reaction vessel. For example, in the example analyzer 100 disclosed above, the second pipetting mechanism 140 is disposed near the second carousel 104 and dispenses a first reagent into reaction vessels at point B. In some examples, the first carousel 102 includes an outer annular array of containers such as, for example, reagents used for first reagent. The second pipetting mechanism 140 aspirates from one of the containers on the outer annular array of containers and dispenses the liquid into a reaction vessel on the second carousel 104 at point B. In some examples, a reagent is to be dispensed into a reaction vessel during the second lockstep, wherein the first lockstep included adding sample to that reaction vessel. Therefore, for the function of dispensing a first reagent, N2 may be set to 2, such that if this is the second lockstep (block 714) for the reaction vessel, the function is performed (block 716), and a first reagent is dispensed into the reaction vessel (block 716) because 4X+2=N2 (e.g., (4*0)+2=2). If X is not zero such as, for example, during subsequent rotations, then the reaction vessel is idle (block 718) and, for example, no functions are performed on the reaction vessel by the operator or robotic mechanisms of the example analyzer 100, 500 at this lockstep because 4X+2≠N2 (e.g., (4*1)+2≠2). Thus, in this example, if the function is to occur only at the second lockstep (e.g., dispensing a first reagent), then the example system will sit idle during each subsequent occurrence of a second lockstep during subsequent rotations until, for example, the reaction vessel is washed and ready for a subsequent test and X is reset to zero for the subsequent implementation of the example process 700.
The example process 700 includes advancing to the next lockstep (block 720) and reading (e.g., analyzing) the contents the reaction vessel. During the advancement in this lockstep, about a quarter of the reaction vessels are passed in front of an analyzer (e.g., the analyzer 158) where the contents of the reaction vessels are analyzed.
The example process includes lockstep4X+3 (block 722). Assuming one full rotation has not yet occurred, X is zero and this is the third lockstep (i.e., lockstep(4*0)+3). During this third lockstep, a third function or test operation may be performed in connection with the reaction vessel if 4X+3=N3 (block 724). Similar to N1 and N2, N3 represents the specific timing or lockstep of a specific function or test operation to be performed in connection with the reaction vessel. For example, in the example analyzer 100 disclosed above, a first pipetting mechanism 130 is disposed within the second diameter 120 of the second carousel 104 and is to dispense a second reagent into reaction vessels on the second carousel 104 point A. In some examples, the first carousel 102 includes an inner annular array of containers 110a-n such as, for example, reagents used for a second reagent. The first pipetting mechanism 130 aspirates from one of the containers on the inner annular array of containers 110a-n and dispenses the liquid into a reaction vessel at point A. Therefore, the function of dispensing a second reagent may be activated for a particular vessel by setting N3 to any number of locksteps. In some examples, a diagnostic test includes adding a sample to a reaction vessel, adding a first reagent to the reaction vessel, and then incubating for a certain amount of time before dispensing the second reagent. In some examples, N3 can be set to 79, such that the reaction vessel will be at the 79th lockstep, or third lockstep of the 19th rotation of a testing (i.e., X=19) when the second reagent is added. Assuming each lockstep is about four seconds, the contents of the reaction vessel incubate for about five minutes before a second reagent is dispensed into the reaction vessel. Therefore, the function of dispensing a second reagent may be triggered by setting N3 to 79 so that at the 79th lockstep (block 724), the function is performed (block 728) and a second reagent is dispensed into the reaction vessel because 4X+3=N3 (e.g., (4*19)+3=79). If X is not 19 such as, for example, during previous rotations or subsequent rotations, then the reaction vessel is idle (block 726) and, for example, no functions are performed on the reaction vessel by the operator or robotic mechanism of the example analyzer 100, 500 at this lockstep because 4X+3≠N3 (e.g., (4*0)+3≠79). Thus, in this example, if the function is to occur only at the 79th lockstep, i.e., the third lockstep of the 19th rotation (e.g., dispensing a second reagent), then the example system will sit idle during each previous and subsequent occurrence of the third lockstep during previous and subsequent rotations until, for example, the reaction vessel is washed and ready for a subsequent test and X is reset to zero for the subsequent implementation of the example process 700.
The example process 700 includes advancing to the next lockstep (block 730) and reading (e.g., analyzing) the contents the reaction vessels that pass the reader.
The example process includes lockstep4X+4 (block 732). At the beginning, when a full rotation has not occurred yet, X is zero and this is the fourth lockstep (i.e., lockstep(4*0)+4). (block 732). During this fourth lockstep, another function or test operation may be performed in connection with the reaction vessel if 4X+4=N4 (block 734). Similar to N1, N2 and N3, N4 represents the specific timing of a specific function or test operation to be performed on the reaction vessel. For example, in the example analyzer 100 disclosed above, the wash zone 162 is disposed to wash reaction vessels at point D. In some examples, a reaction vessel is washed after a test has finished in the reaction vessel. Therefore, N4 can be set at any number to trigger the washing of a vessel. In some examples, a full test of a given sample occurs over about 37 full rotations of the carousel. Therefore, N4 may be set to 152, such that when X=37, the reaction vessel is washed (block 738) because 4X+4=N3 (e.g., (4*38)+4=156). If X is not 37 such as, for example, during the previous 36 rotations, then the reaction vessel is idle (block 736) and, for example, no functions are performed on the reaction vessel by the operator or any robotic mechanism of the example analyzer 100, 500 at this lockstep because 4X+4≠N4 (e.g., (4*0)+4≠156). Thus, in this example, if the function is to occur only at the 156th lockstep, i.e., the fourth lockstep of the 37th rotation (e.g., washing a reaction vessel), then the example system will sit idle during each previous occurrence of the fourth lockstep during previous rotations. Once the reaction vessel is washed and ready for a subsequent test and X is reset to zero for the subsequent implementation of the example process 700.
As noted above, in some examples, if the reaction vessel is washed (block 740), the process 700 ends (block 742) and may start over with a clean reaction vessel for a subsequent test. If the diagnostic testing is not complete, the reaction vessel is idle (block 740), and the reaction carousel advances to the next lockstep (block 744). The example process includes continuing with lockstep4X+1 (block 702), where “1” has been added to X because one full rotation has occurred. Therefore, the start of the second rotation, i.e., the first lockstep of the second rotation will be the fifth lockstep (i.e., lockstep(4*1)+1) (block 702). This process 700 may continue as many times as determined by the testing protocols and scheduling sequences.
Additionally, this example is viewed from the perspective of one reaction vessel progressing through a diagnostic test. However, multiple other reactions may be occurring during the same locksteps and may be performed using this process as well. Although the lockstep triggers N1, N2, N3 and N4 are described above as being associated with adding a sample, a first reagent, a second reagent, and a wash zone, respectively, N1-N4 may be associated with any function, test operation or instrument used in diagnostic testing such as, for example, an in track vortexer (e.g., a mixer), an incubator (e.g., a heat source), etc. Therefore, the process 700 allows a diagnostic test to be customized in regards to the timing and sequencing of the various functions to be performed in connection with one or more vessels and samples disposed therein.
Additionally, this example includes functions N1, N2, N3, and N4, for the respective locksteps during each rotation. However, in other examples, more than one function can be arranged at the each lockstep and distinguished by the number of rotations completed. For example, a first function may be performed during the first lockstep of the first rotation and a second function may be performed during the fifth lockstep (i.e., the first lockstep of the second rotation).
The example timeline 800 also includes dispensing a first reagent using the second pipetting mechanism at point B 804. As mentioned above, in some examples, a first reagent is to be dispensed into a reaction vessel that was previously at point C (i.e., a reaction vessel including a sample). In this example, the second pipetting mechanism begins dispensing a first reagent to a reaction vessel at point B at time or lockstep T2. In this example, T2 may be one lockstep after the lockstep during which sample is added to the first reaction vessel. The second pipetting mechanism continues to dispense the first reagent until T8, which may be, for example, one lockstep after the last sample is dispensed into the last reaction vessel (i.e., once a first reagent has been added to every sample).
The example timeline 800 includes reading 806 the reaction vessels. In some examples, the reader analyzes the reaction vessels as the reaction vessels pass in front of the reader during the advancement portion of the lockstep. Therefore, assuming that each lockstep rotation is a about quarter rotation, and the reaction carousel has 187 reaction vessels, about 47 reaction vessels pass in front of the reader during each lockstep. During the first few locksteps of a diagnostic test, all or a majority of the reaction vessels passing in front of the reader are empty. Therefore, as shown in this example, the reader begins reading at time or lockstep T4, which may be, for example, when the first reaction vessel having a sample and a reagent passes in front of the reader. During every rotation, each reaction vessel is analyzed. In some examples, a full diagnostic test requires 38 reads and, thus, 38 full rotations. Therefore, the reader continues to read until T10, which may be, for example, when the last reaction vessel that was dispensed to has been read 38 times.
The example timeline 800 includes dispensing a second reagent 808, via the first pipetting mechanism, beginning at time or lockstep T5. In some examples, a test sample and a first reagent react for a period of time and then a second reagent is added. To ensure adequate incubation time, the second reagent may be dispensed after a set period of time or number of locksteps, T5. Starting at T5, the first pipetting mechanism dispenses a second reagent into the reaction vessels at point A. This continues until T9, which may be, for example, when the last reaction vessel reaches point A and, thus, all the reaction vessels have had a second reagent dispensed therein.
The example timeline 800 also includes a wash at point D 810. In the example analyzer 100, the wash zone 162 washes reaction vessels at point D. As mentioned above, some reactions may occur over 38 full rotations. After the 38th rotation, the reaction is to be washed out of the reaction vessel. Therefore, the wash begins at T6, which may be, for example, the time or lockstep at which the first reaction vessel has completed its full 38 rotation testing. The wash 810 continues to wash each vessel until T11, which may be, for example, when the last reaction completes its 38 rotation test.
The functions illustrated in
The processor platform 900 of the illustrated example includes a processor 912. The processor 912 of the illustrated example is hardware. For example, the processor 912 can be implemented by one or more integrated circuits, logic circuits, microprocessors or controllers from any desired family or manufacturer.
The processor 912 of the illustrated example includes a local memory 913 (e.g., a cache). The processor 912 of the illustrated example is in communication with a main memory including a volatile memory 814 and a non-volatile memory 916 via a bus 918. The volatile memory 914 may be implemented by Synchronous Dynamic Random Access Memory (SDRAM), Dynamic Random Access Memory (DRAM), RAMBUS Dynamic Random Access Memory (RDRAM) and/or any other type of random access memory device. The non-volatile memory 916 may be implemented by flash memory and/or any other desired type of memory device. Access to the main memory 914, 916 is controlled by a memory controller.
The processor platform 900 of the illustrated example also includes an interface circuit 920. The interface circuit 920 may be implemented by any type of interface standard, such as an Ethernet interface, a universal serial bus (USB), and/or a PCI EXPRESS® interface.
In the illustrated example, one or more input devices 922 are connected to the interface circuit 920. The input device(s) 922 permit(s) a user to enter data and commands into the processor 912. The input device(s) can be implemented by, for example, an audio sensor, a microphone, a camera (still or video), a keyboard, a button, a mouse, a touchscreen, a track-pad, a trackball, isopoint and/or a voice recognition system.
One or more output devices 924 are also connected to the interface circuit 920 of the illustrated example. The output devices 924 can be implemented, for example, by display devices (e.g., a light emitting diode (LED), an organic light emitting diode (OLED), a liquid crystal display, a cathode ray tube display (CRT), a touchscreen, a tactile output device and/or a light emitting diode (LED). The interface circuit 920 of the illustrated example, thus, typically includes a graphics driver card, a graphics driver chip or a graphics driver processor.
The interface circuit 920 of the illustrated example also includes a communication device such as a transmitter, a receiver, a transceiver, a modem and/or network interface card to facilitate exchange of data with external machines (e.g., computing devices of any kind) via a network 926 (e.g., an Ethernet connection, a digital subscriber line (DSL), a telephone line, coaxial cable, a cellular telephone system, etc.).
The processor platform 900 of the illustrated example also includes one or more mass storage devices 928 for storing software and/or data. Examples of such mass storage devices 928 include floppy disk drives, hard drive disks, compact disk drives, BLU-RAY-DISC™ drives, RAID systems, and digital versatile disk (DVD) drives.
Coded instructions 932 to implement the method of
The example analyzers 100 and 500 described herein locate a first carousel beneath a second carousel, thereby reducing the footprint (e.g., width and length dimensions) of the analyzer. The example analyzers 100 and 500 also locate pipetting mechanisms within the dimensions of the first and/or second carousel to reduce the footprint and distance traveled by the pipetting mechanisms. Additionally, by reducing the footprint of the analyzer, the carousels may be relatively wider (e.g., having a greater diameter) and/or high and, thus, include more containers (e.g., reagents) to perform more tests.
Although certain example methods, apparatus and articles of manufacture have been described herein, the scope of coverage of this patent is not limited thereto. On the contrary, this patent covers all methods, apparatus and articles of manufacture fairly falling within the scope of the claims of this patent.
This patent arises from a continuation of U.S. application Ser. No. 15/218,833 know U.S. Pat. No. 10,197,585), titled “AUTOMATED DIAGNOSTIC ANALYZERS HAVING VERTICALLY ARRANGED CAROUSELS AND RELATED METHODS,” filed Jul. 25, 2016, which is a continuation of U.S. application Ser. No. 14/213,018 (now U.S. Pat. No. 9,400,285), titled “AUTOMATED DIAGNOSTIC ANALYZERS HAVING VERTICALLY ARRANGED CAROUSELS AND RELATED METHODS,” filed Mar. 14, 2014, which claims priority to and the benefit of U.S. Provisional Application No. 61/794,060, titled “AUTOMATED DIAGNOSTIC ANALYZERS HAVING VERTICALLY ARRANGED CAROUSELS AND RELATED METHODS,” filed Mar. 15, 2013. U.S. application Ser. No. 15/218,833; U.S. application Ser. No. 14/213,018; and U.S. Provisional Application No. 61/794,060 are incorporated herein by this reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
3449959 | Grimshaw | Jun 1969 | A |
3451433 | Cunningham et al. | Jun 1969 | A |
3484206 | Loebl | Dec 1969 | A |
4738825 | Kelln et al. | Apr 1988 | A |
4774055 | Wakatake et al. | Sep 1988 | A |
4808380 | Minekane | Feb 1989 | A |
4848917 | Benin et al. | Jul 1989 | A |
4849177 | Jordan | Jul 1989 | A |
4906433 | Minekane | Mar 1990 | A |
5037612 | Takahashi et al. | Aug 1991 | A |
5051238 | Umetsu et al. | Sep 1991 | A |
5071625 | Kelln et al. | Dec 1991 | A |
5077013 | Guigan | Dec 1991 | A |
5154896 | Mochida et al. | Oct 1992 | A |
5244633 | Jakubowicz et al. | Sep 1993 | A |
5250440 | Kelln et al. | Oct 1993 | A |
5266268 | Antocci et al. | Nov 1993 | A |
5270212 | Horiuchi et al. | Dec 1993 | A |
5311426 | Donohue et al. | May 1994 | A |
5314825 | Weyrauch et al. | May 1994 | A |
5316726 | Babson et al. | May 1994 | A |
5352612 | Huber et al. | Oct 1994 | A |
5358691 | Clark et al. | Oct 1994 | A |
5360597 | Jakubowicz et al. | Nov 1994 | A |
5419871 | Muszak et al. | May 1995 | A |
5422271 | Chen et al. | Jun 1995 | A |
5424036 | Ushikubo | Jun 1995 | A |
5424212 | Pinsl-Ober et al. | Jun 1995 | A |
5434083 | Mitsumaki et al. | Jul 1995 | A |
5439645 | Saralegui | Aug 1995 | A |
5439646 | Tanimizu et al. | Aug 1995 | A |
5443791 | Cathcart et al. | Aug 1995 | A |
5445794 | Wihlborg | Aug 1995 | A |
5447687 | Lewis et al. | Sep 1995 | A |
5455175 | Wittwer et al. | Oct 1995 | A |
5460780 | Devaney, Jr. et al. | Oct 1995 | A |
5460968 | Yoshida et al. | Oct 1995 | A |
5462715 | Koch et al. | Oct 1995 | A |
5466574 | Liberti et al. | Nov 1995 | A |
5470744 | Astle | Nov 1995 | A |
5482834 | Gillespie | Jan 1996 | A |
5482839 | Ashihara et al. | Jan 1996 | A |
5482861 | Clark et al. | Jan 1996 | A |
5518693 | Tomasso et al. | May 1996 | A |
5525300 | Danssaert et al. | Jun 1996 | A |
5527673 | Reinhartz et al. | Jun 1996 | A |
5536475 | Moubayed et al. | Jul 1996 | A |
5536481 | Mabire et al. | Jul 1996 | A |
5538849 | Uematsu et al. | Jul 1996 | A |
5538976 | Okada et al. | Jul 1996 | A |
5548826 | Sayers | Aug 1996 | A |
5558839 | Matte et al. | Sep 1996 | A |
5559002 | Uzan et al. | Sep 1996 | A |
5567595 | Kok | Oct 1996 | A |
5571325 | Ueyama et al. | Nov 1996 | A |
5571481 | Powell et al. | Nov 1996 | A |
5575976 | Choperena et al. | Nov 1996 | A |
5576215 | Burns et al. | Nov 1996 | A |
5578269 | Yaremko et al. | Nov 1996 | A |
5578270 | Reichler et al. | Nov 1996 | A |
5580524 | Forrest et al. | Dec 1996 | A |
5582796 | Carey et al. | Dec 1996 | A |
5585068 | Panetz et al. | Dec 1996 | A |
5587129 | Kurosaki et al. | Dec 1996 | A |
5589137 | Markin et al. | Dec 1996 | A |
5595707 | Copeland et al. | Jan 1997 | A |
5599501 | Carey et al. | Feb 1997 | A |
5611994 | Bailey et al. | Mar 1997 | A |
5620898 | Yaremko et al. | Apr 1997 | A |
5632399 | Palmieri et al. | May 1997 | A |
5637275 | Carey et al. | Jun 1997 | A |
5639425 | Komiyama et al. | Jun 1997 | A |
5650327 | Copeland et al. | Jul 1997 | A |
5653940 | Carey et al. | Aug 1997 | A |
5654199 | Copeland et al. | Aug 1997 | A |
5654200 | Copeland et al. | Aug 1997 | A |
5656493 | Mullis et al. | Aug 1997 | A |
5658532 | Kurosaki et al. | Aug 1997 | A |
5658799 | Choperena et al. | Aug 1997 | A |
5670114 | Sakazume et al. | Sep 1997 | A |
5670120 | Degenhardt et al. | Sep 1997 | A |
5670375 | Seaton et al. | Sep 1997 | A |
5677188 | Mitsumaki et al. | Oct 1997 | A |
5679309 | Bell | Oct 1997 | A |
5681530 | Kuster et al. | Oct 1997 | A |
5682026 | Auclair et al. | Oct 1997 | A |
5686046 | Malek et al. | Nov 1997 | A |
5693292 | Choperena et al. | Dec 1997 | A |
5698450 | Ringrose et al. | Dec 1997 | A |
5702950 | Tajima | Dec 1997 | A |
5705062 | Knobel | Jan 1998 | A |
5714380 | Neri et al. | Feb 1998 | A |
5716583 | Smethers et al. | Feb 1998 | A |
5717148 | Ely et al. | Feb 1998 | A |
5720377 | Lapeus et al. | Feb 1998 | A |
5720923 | Haff et al. | Feb 1998 | A |
5721141 | Babson et al. | Feb 1998 | A |
5723092 | Babson | Mar 1998 | A |
5730938 | Carbonari et al. | Mar 1998 | A |
5730939 | Kurumada et al. | Mar 1998 | A |
5736101 | Gianino | Apr 1998 | A |
5736105 | Astle | Apr 1998 | A |
5736413 | Uzan et al. | Apr 1998 | A |
5738827 | Marquiss | Apr 1998 | A |
5741461 | Takahashi et al. | Apr 1998 | A |
5741708 | Carey et al. | Apr 1998 | A |
5746977 | Imai et al. | May 1998 | A |
5746978 | Bienhaus et al. | May 1998 | A |
5748978 | Narayan et al. | May 1998 | A |
5750338 | Collins et al. | May 1998 | A |
5762872 | Bühler et al. | Jun 1998 | A |
5762873 | Fanning et al. | Jun 1998 | A |
5773268 | Korenberg et al. | Jun 1998 | A |
5773296 | Montalbano et al. | Jun 1998 | A |
5773662 | Imai et al. | Jun 1998 | A |
5779981 | Danssaert et al. | Jul 1998 | A |
5786182 | Catanzariti et al. | Jul 1998 | A |
5789252 | Fujita et al. | Aug 1998 | A |
5795547 | Moser et al. | Aug 1998 | A |
5795784 | Arnquist et al. | Aug 1998 | A |
5807523 | Watts et al. | Sep 1998 | A |
5814277 | Bell et al. | Sep 1998 | A |
5816998 | Silverstolpe et al. | Oct 1998 | A |
5826129 | Hasebe et al. | Oct 1998 | A |
5827478 | Carey et al. | Oct 1998 | A |
5827479 | Yamazaki et al. | Oct 1998 | A |
5827653 | Sammes et al. | Oct 1998 | A |
5837195 | Malek et al. | Nov 1998 | A |
5843376 | Ishihara et al. | Dec 1998 | A |
5846491 | Choperena et al. | Dec 1998 | A |
5849247 | Uzan et al. | Dec 1998 | A |
5855847 | Oonuma et al. | Jan 1999 | A |
5856194 | Arnquist et al. | Jan 1999 | A |
5863506 | Farren | Jan 1999 | A |
5876668 | Kawashima et al. | Mar 1999 | A |
5876670 | Mitsumaki et al. | Mar 1999 | A |
5882594 | Kawaguchi et al. | Mar 1999 | A |
5882596 | Breeser et al. | Mar 1999 | A |
5882918 | Goffe | Mar 1999 | A |
5885353 | Strodtbeck et al. | Mar 1999 | A |
5885529 | Babson et al. | Mar 1999 | A |
5885530 | Babson et al. | Mar 1999 | A |
5888454 | Leistner et al. | Mar 1999 | A |
5897783 | Howe et al. | Apr 1999 | A |
5902549 | Mimura et al. | May 1999 | A |
5919622 | Macho et al. | Jul 1999 | A |
5928952 | Hutchins et al. | Jul 1999 | A |
5935522 | Swerdlow et al. | Aug 1999 | A |
5948691 | Ekiriwang et al. | Sep 1999 | A |
5955373 | Hutchins et al. | Sep 1999 | A |
5958763 | Goffe | Sep 1999 | A |
5972295 | Hanawa et al. | Oct 1999 | A |
5985215 | Sakazume et al. | Nov 1999 | A |
5985670 | Markin | Nov 1999 | A |
5985671 | Leistner et al. | Nov 1999 | A |
5985672 | Kegelman et al. | Nov 1999 | A |
5988869 | Davidson et al. | Nov 1999 | A |
6019945 | Ohishi et al. | Feb 2000 | A |
6027691 | Watts et al. | Feb 2000 | A |
6033574 | Siddiqi | Mar 2000 | A |
6033880 | Haff et al. | Mar 2000 | A |
6042786 | Oonuma et al. | Mar 2000 | A |
6043880 | Andrews et al. | Mar 2000 | A |
6051101 | Ohtani et al. | Apr 2000 | A |
6056923 | Diamond et al. | May 2000 | A |
6060022 | Pang et al. | May 2000 | A |
6063340 | Lewis et al. | May 2000 | A |
6068393 | Hutchins et al. | May 2000 | A |
6068978 | Zaun et al. | May 2000 | A |
6071395 | Lange | Jun 2000 | A |
6071477 | Auclair et al. | Jun 2000 | A |
6074615 | Lewis et al. | Jun 2000 | A |
6080364 | Mimura et al. | Jun 2000 | A |
6086827 | Horner et al. | Jul 2000 | A |
6096272 | Clark et al. | Aug 2000 | A |
6103193 | Iwahashi et al. | Aug 2000 | A |
6106781 | Rosenberg | Aug 2000 | A |
6110676 | Coull et al. | Aug 2000 | A |
6110678 | Weisburg et al. | Aug 2000 | A |
6117392 | Hanawa et al. | Sep 2000 | A |
6117398 | Bienhaus et al. | Sep 2000 | A |
6117683 | Kodama et al. | Sep 2000 | A |
6143578 | Bendele et al. | Nov 2000 | A |
6146592 | Kawashima et al. | Nov 2000 | A |
6156565 | Maes et al. | Dec 2000 | A |
6165778 | Kedar | Dec 2000 | A |
6174670 | Wittwer et al. | Jan 2001 | B1 |
6232079 | Wittwer et al. | May 2001 | B1 |
6245514 | Wittwer | Jun 2001 | B1 |
6261521 | Mimura et al. | Jul 2001 | B1 |
6267927 | Pomar Longedo et al. | Jul 2001 | B1 |
6270726 | Tyberg et al. | Aug 2001 | B1 |
6277332 | Sucholeiki | Aug 2001 | B1 |
6293750 | Cohen et al. | Sep 2001 | B1 |
6299567 | Forrest et al. | Oct 2001 | B1 |
6300068 | Burg et al. | Oct 2001 | B1 |
6300138 | Gleason et al. | Oct 2001 | B1 |
6319718 | Matsubara et al. | Nov 2001 | B1 |
6332636 | Cohen et al. | Dec 2001 | B1 |
6335166 | Ammann et al. | Jan 2002 | B1 |
6337050 | Takahashi et al. | Jan 2002 | B1 |
6352861 | Copeland et al. | Mar 2002 | B1 |
6374982 | Cohen et al. | Apr 2002 | B1 |
6375898 | Ulrich | Apr 2002 | B1 |
6377342 | Coeurveille | Apr 2002 | B1 |
6386749 | Watts et al. | May 2002 | B1 |
6399952 | Maher et al. | Jun 2002 | B1 |
6436349 | Carey et al. | Aug 2002 | B1 |
6444171 | Sakazume et al. | Sep 2002 | B1 |
6455325 | Tajima | Sep 2002 | B1 |
6461570 | Ishihara | Oct 2002 | B2 |
6472217 | Richards et al. | Oct 2002 | B1 |
6498037 | Carey et al. | Dec 2002 | B1 |
6503751 | Hugh | Jan 2003 | B2 |
6509193 | Tajima | Jan 2003 | B1 |
6517782 | Horner et al. | Feb 2003 | B1 |
6517783 | Horner et al. | Feb 2003 | B2 |
6521183 | Burri et al. | Feb 2003 | B1 |
6522976 | Shiba et al. | Feb 2003 | B2 |
6551833 | Lehtinen et al. | Apr 2003 | B1 |
6562298 | Arnquist et al. | May 2003 | B1 |
6569627 | Wittwer et al. | May 2003 | B2 |
6579717 | Matsubara et al. | Jun 2003 | B1 |
6586234 | Burg et al. | Jul 2003 | B1 |
6592818 | Ishihara et al. | Jul 2003 | B2 |
6597450 | Andrews et al. | Jul 2003 | B1 |
6599749 | Kodama et al. | Jul 2003 | B1 |
6605213 | Ammann et al. | Aug 2003 | B1 |
6632654 | Gebrian et al. | Oct 2003 | B1 |
6709634 | Okada et al. | Mar 2004 | B1 |
6723288 | Devlin, Sr. et al. | Apr 2004 | B2 |
6733728 | Mimura et al. | May 2004 | B1 |
6752967 | Farina et al. | Jun 2004 | B2 |
6764649 | Ammann | Jul 2004 | B2 |
6764650 | Takahashi et al. | Jul 2004 | B2 |
6776961 | Lindsey et al. | Aug 2004 | B2 |
6780617 | Chen | Aug 2004 | B2 |
6787338 | Wittwer et al. | Sep 2004 | B2 |
6825921 | Modlin et al. | Nov 2004 | B1 |
6827901 | Copeland et al. | Dec 2004 | B2 |
6866821 | Friedlander et al. | Mar 2005 | B2 |
6878343 | Sklar et al. | Apr 2005 | B2 |
6890742 | Ammann et al. | May 2005 | B2 |
6911327 | McMillan et al. | Jun 2005 | B2 |
6919058 | Andersson et al. | Jul 2005 | B2 |
6919175 | Bienhaus et al. | Jul 2005 | B1 |
6924152 | Matsubara et al. | Aug 2005 | B2 |
6943029 | Coepland et al. | Sep 2005 | B2 |
6958130 | Gicquel et al. | Oct 2005 | B1 |
7011792 | Mimura et al. | Mar 2006 | B2 |
7028831 | Veiner | Apr 2006 | B2 |
7029922 | Miller | Apr 2006 | B2 |
7033820 | Ammann | Apr 2006 | B2 |
7081226 | Wittwer et al. | Jul 2006 | B1 |
7105351 | Matsubara et al. | Sep 2006 | B2 |
7115090 | Lagarde | Oct 2006 | B2 |
7115384 | Clark et al. | Oct 2006 | B2 |
7118892 | Ammann et al. | Oct 2006 | B2 |
7118918 | Copeland et al. | Oct 2006 | B2 |
7118982 | Govyadinov et al. | Oct 2006 | B2 |
7132082 | Aviles et al. | Nov 2006 | B2 |
7135145 | Ammann et al. | Nov 2006 | B2 |
7138091 | Lee et al. | Nov 2006 | B2 |
7141213 | Pang et al. | Nov 2006 | B1 |
7160998 | Wittwer et al. | Jan 2007 | B2 |
7169356 | Gebrian et al. | Jan 2007 | B2 |
7171863 | Tamura et al. | Feb 2007 | B2 |
7182912 | Carey et al. | Feb 2007 | B2 |
7217391 | Gjerdingen | May 2007 | B2 |
7217513 | Parameswaran et al. | May 2007 | B2 |
7220589 | Richards et al. | May 2007 | B2 |
7250303 | Jakubowicz et al. | Jul 2007 | B2 |
7264111 | Veiner | Sep 2007 | B2 |
7267795 | Ammann et al. | Sep 2007 | B2 |
7270783 | Takase et al. | Sep 2007 | B2 |
7273749 | Wittwer et al. | Sep 2007 | B1 |
7276208 | Sevigny et al. | Oct 2007 | B2 |
7303139 | Rudloff | Dec 2007 | B1 |
7331474 | Veiner et al. | Feb 2008 | B2 |
7341691 | Tamura et al. | Mar 2008 | B2 |
7360984 | Sugiyama et al. | Apr 2008 | B1 |
7361305 | Mimura et al. | Apr 2008 | B2 |
7381370 | Chow et al. | Jun 2008 | B2 |
7384600 | Burns et al. | Jun 2008 | B2 |
7390458 | Burow et al. | Jun 2008 | B2 |
7396509 | Burns | Jul 2008 | B2 |
7402281 | Huynh-Ba et al. | Jul 2008 | B2 |
7407627 | Rosenberg et al. | Aug 2008 | B1 |
7482143 | Ammann et al. | Jan 2009 | B2 |
7524652 | Ammann et al. | Apr 2009 | B2 |
7560255 | Ammann et al. | Jul 2009 | B2 |
7560256 | Ammann et al. | Jul 2009 | B2 |
7575937 | Wiggli et al. | Aug 2009 | B2 |
7611675 | Sevigny et al. | Nov 2009 | B2 |
7622078 | Pagés Pinyol | Nov 2009 | B2 |
7638337 | Ammann et al. | Dec 2009 | B2 |
7641855 | Farina et al. | Jan 2010 | B2 |
7666602 | Ammann et al. | Feb 2010 | B2 |
7666681 | Ammann et al. | Feb 2010 | B2 |
7670553 | Babson | Mar 2010 | B2 |
7670554 | Chow et al. | Mar 2010 | B2 |
7670832 | Wittwer et al. | Mar 2010 | B2 |
7700042 | Matsumoto et al. | Apr 2010 | B2 |
7700043 | Mimura et al. | Apr 2010 | B2 |
7731414 | Vincent et al. | Jun 2010 | B2 |
7731898 | Burkhardt et al. | Jun 2010 | B2 |
7745205 | Wittwer et al. | Jun 2010 | B2 |
7749441 | Hanawa et al. | Jul 2010 | B2 |
7785534 | Watari | Aug 2010 | B2 |
7815858 | Sevigny et al. | Oct 2010 | B2 |
7827874 | Tsujimura et al. | Nov 2010 | B2 |
7837452 | Ignatiev et al. | Nov 2010 | B2 |
7842237 | Shibuya et al. | Nov 2010 | B1 |
7842504 | Devlin, Sr. | Nov 2010 | B2 |
7850914 | Veiner et al. | Dec 2010 | B2 |
7854892 | Veiner et al. | Dec 2010 | B2 |
7855084 | Jakubowicz et al. | Dec 2010 | B2 |
7858032 | Le Comte et al. | Dec 2010 | B2 |
7867777 | Aviles et al. | Jan 2011 | B2 |
7910294 | Karlsen | Mar 2011 | B2 |
7939036 | Burkhardt et al. | May 2011 | B2 |
7941904 | Smith | May 2011 | B2 |
7943100 | Rousseau | May 2011 | B2 |
7947225 | Itoh | May 2011 | B2 |
7951329 | Malyarov et al. | May 2011 | B2 |
7964140 | Watari | Jun 2011 | B2 |
7985375 | Edens et al. | Jul 2011 | B2 |
7998409 | Veiner et al. | Aug 2011 | B2 |
7998432 | Rousseau | Aug 2011 | B2 |
7998751 | Evers et al. | Aug 2011 | B2 |
8003050 | Burkhardt et al. | Aug 2011 | B2 |
8012419 | Ammann et al. | Sep 2011 | B2 |
8038941 | Devlin, Sr. | Oct 2011 | B2 |
8038942 | Pang et al. | Oct 2011 | B2 |
8047086 | Smith | Nov 2011 | B2 |
8066943 | Kegelman et al. | Nov 2011 | B2 |
8071053 | Matsuzaki et al. | Dec 2011 | B2 |
8097211 | Hamada et al. | Jan 2012 | B2 |
8114351 | Degenhardt et al. | Feb 2012 | B2 |
8119080 | Wiggli et al. | Feb 2012 | B2 |
8137620 | Ammann et al. | Mar 2012 | B2 |
8142740 | Self et al. | Mar 2012 | B2 |
8147777 | Schacher et al. | Apr 2012 | B2 |
8153061 | Walters et al. | Apr 2012 | B2 |
8154899 | Degroot | Apr 2012 | B2 |
8158058 | Shiba et al. | Apr 2012 | B2 |
8161831 | Fukuma | Apr 2012 | B2 |
8163239 | Fujita | Apr 2012 | B2 |
8178043 | Burkhardt et al. | May 2012 | B2 |
8187558 | Jacobs et al. | May 2012 | B2 |
8192992 | Ammann et al. | Jun 2012 | B2 |
8221682 | Ammann et al. | Jul 2012 | B2 |
8226387 | Ignatiev | Jul 2012 | B2 |
8234941 | Fukuda et al. | Aug 2012 | B2 |
8257650 | Chow et al. | Sep 2012 | B2 |
8257664 | Ogusu | Sep 2012 | B2 |
8262994 | Hamada et al. | Sep 2012 | B2 |
8262999 | Kaneblei et al. | Sep 2012 | B2 |
8266973 | Maeda et al. | Sep 2012 | B2 |
8293191 | Kohara et al. | Oct 2012 | B2 |
8309358 | Ammann et al. | Nov 2012 | B2 |
8318500 | Ammann et al. | Nov 2012 | B2 |
8329101 | Fujita | Dec 2012 | B2 |
8333936 | Miyashita et al. | Dec 2012 | B2 |
8337753 | Ammann et al. | Dec 2012 | B2 |
8343423 | Mori et al. | Jan 2013 | B2 |
8343754 | Wittwer et al. | Jan 2013 | B2 |
8343770 | Hamada et al. | Jan 2013 | B2 |
8354078 | Shohmi et al. | Jan 2013 | B2 |
8355132 | Xia et al. | Jan 2013 | B2 |
8356525 | Hamada et al. | Jan 2013 | B2 |
8357538 | Self et al. | Jan 2013 | B2 |
8366997 | Degroot | Feb 2013 | B2 |
8383039 | Zhou et al. | Feb 2013 | B2 |
8431079 | Rosenberg et al. | Apr 2013 | B2 |
8501496 | Zuk et al. | Aug 2013 | B2 |
8545757 | Utsugi et al. | Oct 2013 | B2 |
8556564 | Miller | Oct 2013 | B2 |
9274133 | Kraemer et al. | Mar 2016 | B2 |
10197585 | Ochranek et al. | Feb 2019 | B2 |
20020155590 | Gerbian et al. | Oct 2002 | A1 |
20020164807 | Itaya et al. | Nov 2002 | A1 |
20040134750 | Luoma, II | Jul 2004 | A1 |
20050014285 | Miller | Jan 2005 | A1 |
20050220670 | Palmieri et al. | Oct 2005 | A1 |
20050249634 | Devlin, Sr. | Nov 2005 | A1 |
20060159587 | Fechtner et al. | Jul 2006 | A1 |
20060263248 | Gomm et al. | Nov 2006 | A1 |
20060286004 | Jacobs et al. | Dec 2006 | A1 |
20070010019 | Luoma, II | Jan 2007 | A1 |
20070059209 | Pang et al. | Mar 2007 | A1 |
20070092390 | Ignatiev et al. | Apr 2007 | A1 |
20070172902 | Zhang et al. | Jul 2007 | A1 |
20080145939 | Jakubowicz et al. | Jun 2008 | A1 |
20080193332 | Talmer et al. | Aug 2008 | A1 |
20090017491 | Lemme et al. | Jan 2009 | A1 |
20090129979 | Kegelman et al. | May 2009 | A1 |
20090148345 | Hamazumi et al. | Jun 2009 | A1 |
20090227033 | Hamada et al. | Sep 2009 | A1 |
20090258414 | Wittwer et al. | Oct 2009 | A1 |
20100111765 | Gomm et al. | May 2010 | A1 |
20100126286 | Self et al. | May 2010 | A1 |
20100187253 | Vincent et al. | Jul 2010 | A1 |
20100205139 | Xia et al. | Aug 2010 | A1 |
20100276445 | Jacobs et al. | Nov 2010 | A1 |
20100330609 | Nagai et al. | Dec 2010 | A1 |
20100332144 | Nagai et al. | Dec 2010 | A1 |
20110044834 | Ignatiev | Feb 2011 | A1 |
20110097240 | Yamashita et al. | Apr 2011 | A1 |
20110157580 | Nogami et al. | Jun 2011 | A1 |
20110293475 | Rosenberg et al. | Dec 2011 | A1 |
20110312082 | Silverbrook et al. | Dec 2011 | A1 |
20120039748 | Mimura et al. | Feb 2012 | A1 |
20120039771 | Utsugi et al. | Feb 2012 | A1 |
20120114526 | Watanabe et al. | May 2012 | A1 |
20120156764 | Kondo | Jun 2012 | A1 |
20120183438 | Shiba et al. | Jul 2012 | A1 |
20120218854 | Behringer et al. | Aug 2012 | A1 |
20120258004 | Ignatiev et al. | Oct 2012 | A1 |
20120294763 | Fukuda et al. | Nov 2012 | A1 |
20120301359 | Kraemer et al. | Nov 2012 | A1 |
20130017535 | Frey et al. | Jan 2013 | A1 |
20130064737 | Mori et al. | Mar 2013 | A1 |
20130065797 | Silbert et al. | Mar 2013 | A1 |
20130078617 | Ueda et al. | Mar 2013 | A1 |
20130089464 | Sakashita et al. | Apr 2013 | A1 |
20130112014 | Hamada et al. | May 2013 | A1 |
20130125675 | Muller et al. | May 2013 | A1 |
20130280129 | Watanabe et al. | Oct 2013 | A1 |
20130280130 | Sarwar et al. | Oct 2013 | A1 |
20130323758 | Oguri et al. | Dec 2013 | A1 |
20140011295 | Ammann et al. | Jan 2014 | A1 |
20140093975 | Wang et al. | Apr 2014 | A1 |
20140147922 | Knofe et al. | May 2014 | A1 |
20140248619 | Ammann et al. | Sep 2014 | A1 |
20140322080 | Sarwar et al. | Oct 2014 | A1 |
20150037211 | Wang et al. | Feb 2015 | A1 |
20150079695 | Pollack et al. | Mar 2015 | A1 |
20160334430 | Ochranek et al. | Nov 2016 | A1 |
Number | Date | Country |
---|---|---|
100448969 | Jan 2009 | CN |
102221625 | Oct 2011 | CN |
102520200 | Jun 2012 | CN |
112010001896 | Jun 2012 | DE |
0576291 | Dec 1993 | EP |
0779514 | Jun 1997 | EP |
0871892 | Jun 1997 | EP |
0831330 | Mar 1998 | EP |
1414573 | Mar 2003 | EP |
2068154 | Jun 2009 | EP |
2362228 | Aug 2011 | EP |
2808683 | Dec 2014 | EP |
357019667 | Feb 1982 | JP |
359116047 | Jul 1984 | JP |
61095248 | May 1986 | JP |
63-150375 | Oct 1988 | JP |
S63150375 | Oct 1988 | JP |
H01277761 | Nov 1989 | JP |
H0526883 | Feb 1993 | JP |
406027004 | Feb 1994 | JP |
H0634641 | Feb 1994 | JP |
H0666812 | Mar 1994 | JP |
407181129 | Jul 1995 | JP |
H1062432 | Mar 1998 | JP |
2001165937 | Jun 2001 | JP |
2001305145 | Oct 2001 | JP |
2002503346 | Jan 2002 | JP |
3582240 | Oct 2004 | JP |
2005128037 | May 2005 | JP |
2005533641 | Nov 2005 | JP |
2006034639 | Feb 2006 | JP |
2006506541 | Feb 2006 | JP |
2008224439 | Sep 2008 | JP |
2008309661 | Dec 2008 | JP |
2009031204 | Feb 2009 | JP |
2009053027 | Mar 2009 | JP |
2009145202 | Jul 2009 | JP |
2009288094 | Dec 2009 | JP |
2010101726 | May 2010 | JP |
2010217047 | Sep 2010 | JP |
2010533299 | Oct 2010 | JP |
2010267936 | Nov 2010 | JP |
2011149832 | Aug 2011 | JP |
2012021926 | Feb 2012 | JP |
2012132721 | Jul 2012 | JP |
2012173180 | Sep 2012 | JP |
2012189611 | Oct 2012 | JP |
2012233923 | Nov 2012 | JP |
2012251804 | Dec 2012 | JP |
2012251909 | Dec 2012 | JP |
2012255664 | Dec 2012 | JP |
5178891 | Apr 2013 | JP |
227044 | Jul 1994 | TW |
9315408 | Aug 1993 | WO |
9722006 | Jun 1997 | WO |
03018195 | Mar 2003 | WO |
2009009419 | Jan 2009 | WO |
2010026837 | Mar 2010 | WO |
2010095375 | Aug 2010 | WO |
2010106885 | Sep 2010 | WO |
2012114675 | Aug 2012 | WO |
2012137019 | Oct 2012 | WO |
2013053023 | Apr 2013 | WO |
2013064561 | May 2013 | WO |
2013064562 | May 2013 | WO |
2013111484 | Aug 2013 | WO |
Entry |
---|
The International Searching Authority, “International Preliminary Report on Patentability and Written Opinion”, issued in connection with International patent Application No. PCT/US2014/029118, dated Sep. 24, 2015, 6 pages. |
The European Patent Office, “Communication Pursuant to Rules 161 and 162 EPC”, issued in connection with European Patent Application 14717953.5, dated Oct. 23, 2015, 2 pages. |
The International Searching Authority, “International Search Report and Written Opinion” issued in connection with International Patent Application No. PCT/US2013/07804, dated Sep. 19, 2014, 16 pages. |
The International Searching Authority “International Search Report and Written Opinion”, issued in connection with corresponding International Patent Application No. PCT/US2014/029138, dated Jun. 23, 2014, 8 pages. |
The International Searching Authority, “International Search Report and Written Opinion”, issued in connection with corresponding International Patent Application No. PCT/US2014/029118, dated Jun. 27, 2014, 9 pages. |
The International Searching Authority, “Invitation to Pay Additional Fees and, Where Applicable, Protest Fee and Communication Relating to the Results of the Partial International Search”, issued in connection with corresponding International Patent Application No. PCT/US2013/078041, dated Apr. 9, 2014, 6 pages. |
The Untied States Patent and Trademark Office “Office Action”, issued in connection with U.S. Appl. No. 14/213,048, dated Apr. 23, 2015, 12 pages. |
The Untied States Patent and Trademark Office, “Notice of Allowance and Fee(s) Due”, issued by the in connection with U.S. Appl. No. 14/213,048, dated Jan. 12, 2016, 10 pages. |
The Untied States Patent and Trademark Office, “Notice of Allowance and Fee(s) Due”, issued in connection with U.S. Appl. No. 14/213,048, dated Apr. 11, 2016, 4 pages. |
The Untied States Patent and Trademark Office “Office Action”, issued in connection with U.S. Appl. No. 14/213,018, dated Apr. 29, 2015, 13 pages. |
The Untied States Patent and Trademark Office, “Final Rejection”, issued in connection with U.S. Appl. No. 14/213,018, dated Jan. 7, 2016, 15 pages. |
The Untied States Patent and Trademark Office, “Notice of Allowance and Fee(s) Due”, issued in connection with U.S. Appl. No. 14/213,018, dated Mar. 16, 2016, 2016, 10 pages. |
The Untied States Patent and Trademark Office, “Notice of Allowance and Fee(s) Due”, issued in connection with U.S. Appl. No. 14/213,018, dated Jun. 15, 2016, 4 pages. |
The Untied States Patent and Trademark Office, “Notice of Allowance and Fee(s) Due”, issued in connection with U.S. Appl. No. 14/213,018, dated Jun. 23, 2016, 4 pages. |
The State Intellectual Property Office of the P.R. China, “Notification of the First Office Action and Search Report”, issued in connection with Chinese Patent Application No. 201480027844.3, dated Jul. 5 2016, 22 pages. |
Japanese Patent Office, “Office Action,” issued in connection with Japanese Patent Application No. 2016-502992, dated Jan. 16, 2018, 8 pages. |
Japanese Patent Office, “First Office Action,” issued in connection with Japanese Patent Application No. 2016-502992, dated May 30, 2017, 15 pages. |
State Intellectual Property Office of China, “Second Office Action,” issued in connection with Chinese Patent Application No. 201480027844.3, dated Apr. 7, 2017, 19 pages. |
State Intellectual Property Office of China, “Third Office Action,” issued in connection with Chinese Patent Application No. 201480027844.3, dated Oct. 26, 2017, 3 pages. |
Untied States Patent & Trademark Office, “Restriction Requirement”, issued in connection with U.S. Appl. No. 15/218,833, dated Feb. 23, 2018, 7 pages. |
Untied States Patent & Trademark Office, “Non-Final Office Action”, issued in connection with U.S. Appl. No. 15/218,833, dated May 8, 2018, 74 pages. |
United States Patent & Trademark Office, “Non-Final Office Action”, issued in connection with U.S. Appl. No. 15/218,833, dated May 8, 2018, 74 pages. |
Japanese Patent Office, “Decision of Patent”, issued in connection with Japanese Application No. 2018-107930, dated Jan. 28, 2020, 3 pages. |
Japanese Paptent Office, “First Office Action”, issued in connection with Japanese Application No. 2018-107930, dated Jun. 25, 2019, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20190137530 A1 | May 2019 | US |
Number | Date | Country | |
---|---|---|---|
61794060 | Mar 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15218833 | Jul 2016 | US |
Child | 16240105 | US | |
Parent | 14213018 | Mar 2014 | US |
Child | 15218833 | US |